6oiq - Revision history

OCA at 12:42, 17 July 2019

OCA — Wed, 17 Jul 2019 12:42:08 GMT

←Older revision		Revision as of 12:42, 17 July 2019
Line 3:		Line 3:
	<StructureSection load='6oiq' size='340' side='right'caption='[[6oiq]], [[Resolution\|resolution]] 1.75Å' scene=''>		<StructureSection load='6oiq' size='340' side='right'caption='[[6oiq]], [[Resolution\|resolution]] 1.75Å' scene=''>
	== Structural highlights ==		== Structural highlights ==
-	<table><tr><td colspan='2'>[[6oiq]] is a 1 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=6OIQ OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=6OIQ FirstGlance]. <br>	+	<table><tr><td colspan='2'>[[6oiq]] is a 1 chain structure with sequence from [http://en.wikipedia.org/wiki/Human Human]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=6OIQ OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=6OIQ FirstGlance]. <br>
	</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand\|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=GOL:GLYCEROL'>GOL</scene>, <scene name='pdbligand=MLV:2-fluoro-N-(phenylsulfonyl)[1,1-biphenyl]-3-carbohydrazide'>MLV</scene>, <scene name='pdbligand=ZN:ZINC+ION'>ZN</scene></td></tr>		</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand\|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=GOL:GLYCEROL'>GOL</scene>, <scene name='pdbligand=MLV:2-fluoro-N-(phenylsulfonyl)[1,1-biphenyl]-3-carbohydrazide'>MLV</scene>, <scene name='pdbligand=ZN:ZINC+ION'>ZN</scene></td></tr>
	<tr id='NonStdRes'><td class="sblockLbl"><b>[[Non-Standard_Residue\|NonStd Res:]]</b></td><td class="sblockDat"><scene name='pdbligand=ALY:N(6)-ACETYLLYSINE'>ALY</scene></td></tr>		<tr id='NonStdRes'><td class="sblockLbl"><b>[[Non-Standard_Residue\|NonStd Res:]]</b></td><td class="sblockDat"><scene name='pdbligand=ALY:N(6)-ACETYLLYSINE'>ALY</scene></td></tr>
		+	<tr id='gene'><td class="sblockLbl"><b>[[Gene\|Gene:]]</b></td><td class="sblockDat">KAT8, MOF, MYST1, PP7073 ([http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Info&srchmode=5&id=9606 HUMAN])</td></tr>
	<tr id='activity'><td class="sblockLbl"><b>Activity:</b></td><td class="sblockDat"><span class='plainlinks'>[http://en.wikipedia.org/wiki/Histone_acetyltransferase Histone acetyltransferase], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=2.3.1.48 2.3.1.48] </span></td></tr>		<tr id='activity'><td class="sblockLbl"><b>Activity:</b></td><td class="sblockDat"><span class='plainlinks'>[http://en.wikipedia.org/wiki/Histone_acetyltransferase Histone acetyltransferase], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=2.3.1.48 2.3.1.48] </span></td></tr>
	<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=6oiq FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=6oiq OCA], [http://pdbe.org/6oiq PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=6oiq RCSB], [http://www.ebi.ac.uk/pdbsum/6oiq PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=6oiq ProSAT]</span></td></tr>		<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=6oiq FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=6oiq OCA], [http://pdbe.org/6oiq PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=6oiq RCSB], [http://www.ebi.ac.uk/pdbsum/6oiq PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=6oiq ProSAT]</span></td></tr>
Line 11:		Line 12:
	== Function ==		== Function ==
	[[http://www.uniprot.org/uniprot/KAT8_HUMAN KAT8_HUMAN]] Histone acetyltransferase which may be involved in transcriptional activation. May influence the function of ATM. As part of the MSL complex it is involved in acetylation of nucleosomal histone H4 producing specifically H4K16ac. As part of the NSL complex it may be involved in acetylation of nucleosomal histone H4 on several lysine residues. That activity is less specific than the one of the MSL complex.<ref>PMID:12397079</ref> <ref>PMID:15923642</ref> <ref>PMID:20018852</ref>		[[http://www.uniprot.org/uniprot/KAT8_HUMAN KAT8_HUMAN]] Histone acetyltransferase which may be involved in transcriptional activation. May influence the function of ATM. As part of the MSL complex it is involved in acetylation of nucleosomal histone H4 producing specifically H4K16ac. As part of the NSL complex it may be involved in acetylation of nucleosomal histone H4 on several lysine residues. That activity is less specific than the one of the MSL complex.<ref>PMID:12397079</ref> <ref>PMID:15923642</ref> <ref>PMID:20018852</ref>
		+	<div style="background-color:#fffaf0;">
		+	== Publication Abstract from PubMed ==
		+	A high-throughput screen for inhibitors of the histone acetyltransferase, KAT6A, led to identification of an aryl sulfonohydrazide derivative that inhibited KAT6A with an IC50 of 0.87M. Elaboration of the structure-activity relationship (SAR) and medicinal chemistry optimization led to discovery of WM-8014 (84), a highly potent inhibitor of KAT6A (IC50 = 0.008 M). WM-8014 competes with Ac-CoA and X-ray crystallographic analysis demonstrated binding to the Ac-CoA binding site. Through inhibition of KAT6A activity, WM-8014 induces cellular senescence and represents a unique pharmacological tool.
		+
		+	Discovery of benzoylsulfonohydrazides as potent inhibitors of the histone acetyltransferase KAT6A.,Leaver D, Cleary B, Nguyen NT, Priebbenow DL, Lagiakos HR, Sanchez J, Xue L, Huang F, Sun Y, Mujumdar P, Mudududdla R, Varghese S, Teguh S, Charman SA, White K, Katneni K, Cuellar M, Strasser J, Dahlin J, Walters MA, Street I, Monahan B, Jarman KE, Jousset Sabroux H, Falk H, Chung M, Hermans S, Parker MW, Thomas T, Baell JB J Med Chem. 2019 Jun 29. doi: 10.1021/acs.jmedchem.9b00665. PMID:31256587<ref>PMID:31256587</ref>
		+
		+	From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br>
		+	</div>
		+	<div class="pdbe-citations 6oiq" style="background-color:#fffaf0;"></div>
	== References ==		== References ==
	<references/>		<references/>
Line 16:		Line 26:
	</StructureSection>		</StructureSection>
	[[Category: Histone acetyltransferase]]		[[Category: Histone acetyltransferase]]
		+	[[Category: Human]]
	[[Category: Large Structures]]		[[Category: Large Structures]]
	[[Category: Baell, J B]]		[[Category: Baell, J B]]

OCA at 05:58, 3 July 2019

OCA — Wed, 03 Jul 2019 05:58:38 GMT

←Older revision		Revision as of 05:58, 3 July 2019
Line 1:		Line 1:
-	'''Unreleased structure'''

-	~~The entry~~ 6oiq ~~is ON HOLD until Paper Publication~~	+	==Crystal structure of MYST acetyltransferase domain in complex with inhibitor 63==
-		+	<StructureSection load='6oiq' size='340' side='right'caption='[[6oiq]], [[Resolution\|resolution]] 1.75Å' scene=''>
-	~~Authors~~: ~~Hermans, S~~.J., ~~Chung~~, M.C., ~~Parker~~, M.W., ~~Thomas~~, T., ~~Baell~~, J.B.	+	== Structural highlights ==
-		+	<table><tr><td colspan='2'>[[6oiq]] is a 1 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=6OIQ OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=6OIQ FirstGlance]. <br>
-	~~Description~~: ~~Crystal structure of MYST~~ acetyltransferase ~~domain~~ in complex ~~with inhibitor~~	+	</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand\|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=GOL:GLYCEROL'>GOL</scene>, <scene name='pdbligand=MLV:2-fluoro-N-(phenylsulfonyl)[1,1-biphenyl]-3-carbohydrazide'>MLV</scene>, <scene name='pdbligand=ZN:ZINC+ION'>ZN</scene></td></tr>
-	[[Category: ~~Unreleased~~ Structures]]	+	<tr id='NonStdRes'><td class="sblockLbl"><b>[[Non-Standard_Residue\|NonStd Res:]]</b></td><td class="sblockDat"><scene name='pdbligand=ALY:N(6)-ACETYLLYSINE'>ALY</scene></td></tr>
		+	<tr id='activity'><td class="sblockLbl"><b>Activity:</b></td><td class="sblockDat"><span class='plainlinks'>[http://en.wikipedia.org/wiki/Histone_acetyltransferase Histone acetyltransferase], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=2.3.1.48 2.3.1.48] </span></td></tr>
		+	<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=6oiq FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=6oiq OCA], [http://pdbe.org/6oiq PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=6oiq RCSB], [http://www.ebi.ac.uk/pdbsum/6oiq PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=6oiq ProSAT]</span></td></tr>
		+	</table>
		+	== Function ==
		+	[[http://www.uniprot.org/uniprot/KAT8_HUMAN KAT8_HUMAN]] Histone acetyltransferase which may be involved in transcriptional activation. May influence the function of ATM. As part of the MSL complex it is involved in acetylation of nucleosomal histone H4 producing specifically H4K16ac. As part of the NSL complex it may be involved in acetylation of nucleosomal histone H4 on several lysine residues. That activity is less specific than the one of the MSL complex.<ref>PMID:12397079</ref> <ref>PMID:15923642</ref> <ref>PMID:20018852</ref>
		+	== References ==
		+	<references/>
		+	__TOC__
		+	</StructureSection>
		+	[[Category: Histone acetyltransferase]]
		+	[[Category: Large Structures]]
		+	[[Category: Baell, J B]]
		+	[[Category: Chung, M C]]
		+	[[Category: Hermans, S J]]
		+	[[Category: Parker, M W]]
	[[Category: Thomas, T]]		[[Category: Thomas, T]]
-	[[Category: ~~Parker, M.W~~]]	+	[[Category: Complex]]
-	[[Category: ~~Baell, J.B~~]]	+	[[Category: Inhibitor]]
-	[[Category: ~~Chung, M.C~~]]	+	[[Category: Myst]]
-	[[Category: ~~Hermans, S.J~~]]	+	[[Category: Transferase]]
		+	[[Category: Transferase-transferase inhibitor complex]]

OCA at 05:44, 21 May 2019

OCA — Tue, 21 May 2019 05:44:43 GMT

←Older revision		Revision as of 05:44, 21 May 2019
Line 1:		Line 1:
	'''Unreleased structure'''		'''Unreleased structure'''

-	The entry 6oiq is ON HOLD	+	The entry 6oiq is ON HOLD until Paper Publication

	Authors: Hermans, S.J., Chung, M.C., Parker, M.W., Thomas, T., Baell, J.B.		Authors: Hermans, S.J., Chung, M.C., Parker, M.W., Thomas, T., Baell, J.B.
Line 7:		Line 7:
	Description: Crystal structure of MYST acetyltransferase domain in complex with inhibitor		Description: Crystal structure of MYST acetyltransferase domain in complex with inhibitor
	[[Category: Unreleased Structures]]		[[Category: Unreleased Structures]]
		+	[[Category: Thomas, T]]
	[[Category: Parker, M.W]]		[[Category: Parker, M.W]]
	[[Category: Baell, J.B]]		[[Category: Baell, J.B]]
	[[Category: Chung, M.C]]		[[Category: Chung, M.C]]
	[[Category: Hermans, S.J]]		[[Category: Hermans, S.J]]
-	[[Category: Thomas, T]]

OCA: Protected "6oiq" [edit=sysop:move=sysop]

OCA — Wed, 17 Apr 2019 04:15:26 GMT

Protected "6oiq" [edit=sysop:move=sysop]

←Older revision

Revision as of 04:15, 17 April 2019

OCA: New page: '''Unreleased structure''' The entry 6oiq is ON HOLD Authors: Hermans, S.J., Chung, M.C., Parker, M.W., Thomas, T., Baell, J.B. Description: Crystal structure of MYST acetyltransferase...

OCA — Wed, 17 Apr 2019 04:15:25 GMT

New page: '''Unreleased structure''' The entry 6oiq is ON HOLD Authors: Hermans, S.J., Chung, M.C., Parker, M.W., Thomas, T., Baell, J.B. Description: Crystal structure of MYST acetyltransferase...

New page

'''Unreleased structure'''

The entry 6oiq is ON HOLD

Authors: Hermans, S.J., Chung, M.C., Parker, M.W., Thomas, T., Baell, J.B.

Description: Crystal structure of MYST acetyltransferase domain in complex with inhibitor
[[Category: Unreleased Structures]]
[[Category: Parker, M.W]]
[[Category: Baell, J.B]]
[[Category: Chung, M.C]]
[[Category: Hermans, S.J]]
[[Category: Thomas, T]]